Format

Send to

Choose Destination
Cell. 2011 Sep 30;147(1):26-31. doi: 10.1016/j.cell.2011.09.016.

A blueprint for advancing genetics-based cancer therapy.

Author information

1
Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA. william.sellers@novartis.com

Abstract

In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic contributions to the therapy of disease more broadly.

PMID:
21962504
DOI:
10.1016/j.cell.2011.09.016
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center